PHATHOM PHARMA ($PHAT) posted quarterly earnings results on Thursday, March 6th. The company reported earnings of -$0.79 per share, beating estimates of -$1.30 by $0.51. The company also reported revenue of $29,660,000, beating estimates of $25,407,945 by $4,252,055.
You can see Quiver Quantitative's $PHAT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
PHATHOM PHARMA Insider Trading Activity
PHATHOM PHARMA insiders have traded $PHAT stock on the open market 7 times in the past 6 months. Of those trades, 2 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $PHAT stock by insiders over the last 6 months:
- TERRIE CURRAN (President and Chief Executive) sold 19,109 shares for an estimated $125,884
- FRANK KARBE purchased 12,500 shares for an estimated $99,083
- ASIT PARIKH purchased 10,000 shares for an estimated $81,248
- AZMI NABULSI (Chief Operating Officer) has made 0 purchases and 2 sales selling 9,004 shares for an estimated $60,900.
- MOLLY HENDERSON (CFO and CBO) has made 0 purchases and 2 sales selling 7,874 shares for an estimated $53,698.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
PHATHOM PHARMA Hedge Fund Activity
We have seen 92 institutional investors add shares of PHATHOM PHARMA stock to their portfolio, and 55 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PORTOLAN CAPITAL MANAGEMENT, LLC removed 1,699,918 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $13,803,334
- GILDER GAGNON HOWE & CO LLC removed 1,581,273 shares (-97.4%) from their portfolio in Q4 2024, for an estimated $12,839,936
- WOODLINE PARTNERS LP removed 1,571,720 shares (-61.1%) from their portfolio in Q4 2024, for an estimated $12,762,366
- TAKEDA PHARMACEUTICAL CO LTD removed 1,557,063 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $28,151,699
- ORBIMED ADVISORS LLC removed 1,449,073 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $11,766,472
- FEDERATED HERMES, INC. removed 1,403,638 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $11,397,540
- WASATCH ADVISORS LP added 1,311,986 shares (+531.3%) to their portfolio in Q4 2024, for an estimated $10,653,326
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
